Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment
about
Molecular Diagnosis of Hemorrhagic Fever with Renal Syndrome Caused by Puumala VirusThe correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study.Association of low serum TGF-β level in hantavirus infected patients with severe diseaseClinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype SochiHuman hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways.Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus diseaseCytotoxic immune responses in the lungs correlate to disease severity in patients with hantavirus infection.Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus.Prediction of B Cell Epitopes Among Hantavirus Strains Causing Hemorragic Fever With Renal Syndrome.Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant.Anti-DHAV-1 reproduction and immuno-regulatory effects of a flavonoid prescription on duck virus hepatitis.Viral load of patients with hantavirus pulmonary syndrome in Argentina.Fatal Puumala Hantavirus Disease: Involvement of Complement Activation and Vascular Leakage in the Pathobiology.Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome.
P2860
Q24289107-78BA62DE-9C16-4251-AB94-744CE5DA2220Q34048432-FF39334F-9DBB-43D4-B885-9E9713BE714AQ35440371-3F774370-53E0-4242-88FC-D85E9B5392F2Q36191969-A844EEE3-65A4-4B28-94A4-E4A2AEA62344Q36412610-2B1F5CE3-0FD2-46A8-A6B7-2CC9A2FDA6E8Q37547658-211B46CB-D062-41D1-A57D-753D7A6B5C12Q39834120-116A7EF6-F50C-408A-8CF6-049BF2760E64Q40066130-A0EB233C-B151-4A17-9D4C-9DEBEF54DCF7Q40084920-44127B53-6A09-4D38-804C-96EE48A0B5DDQ40178559-DC791E87-C41F-40F9-8DD1-35AF227CE8BAQ40254558-7C2CDAE4-9C89-46F7-BBF2-58D308266709Q41152443-8DD6C584-BF87-4640-BC32-9A8CBC541B23Q47133862-7289D9F9-06D6-4E14-B156-70F49DD63500Q54210799-6DA6680A-246C-4834-BBA4-502622F0D7E4
P2860
Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Viral load and humoral immune ...... ts--implications for treatment
@ast
Viral load and humoral immune ...... ts--implications for treatment
@en
Viral load and humoral immune ...... ts--implications for treatment
@nl
type
label
Viral load and humoral immune ...... ts--implications for treatment
@ast
Viral load and humoral immune ...... ts--implications for treatment
@en
Viral load and humoral immune ...... ts--implications for treatment
@nl
prefLabel
Viral load and humoral immune ...... ts--implications for treatment
@ast
Viral load and humoral immune ...... ts--implications for treatment
@en
Viral load and humoral immune ...... ts--implications for treatment
@nl
P2093
P2860
P356
P1476
Viral load and humoral immune ...... ts--implications for treatment
@en
P2093
P2860
P304
P356
10.1111/1469-0691.12259
P577
2013-06-07T00:00:00Z